Latest Disruptive Pharma News & Updates

See the latest news and media coverage for Disruptive Pharma. We track all announcements, press releases, and industry mentions in real time, all in one place.

Disruptive Pharma

Pharmaceutical formulation technology company

guardtherapeutics.com

Headquarters: Stockholm, Sweden
Company type: Public company
Number of employees: 5–10
Industry: Pharmaceuticals

Last updated September 22

Latest news about Disruptive Pharma

In short: Disruptive Pharma, formerly Guard Therapeutics, completed a reverse takeover, renamed, and sold its GTX platform to focus on Formulite®.

Company announcements

September 22 Disruptive Pharma

Disruptive Pharma sells GTX platform and retains royalty rights

The transaction involves less initial compensation but future payments at development stages as well as royalties. Focus shifts to Formulite®.

September 16 Disruptive Pharma

Disruptive Pharma hires Tobias Assander as Manufacturing and Process Development Lead

Assander returns to the company and will lead process development, scale-up, and manufacturing of the Formulite® technology.

August 20 Disruptive Pharma

Guard Therapeutics publishes interim report for January–June 2026

The report shows zero revenues and a loss. The company carried out a reverse acquisition of Disruptive Pharma, changed its name and received a new listing.

August 18 Disruptive Pharma

Guard Therapeutics changes name to Disruptive Pharma and starts trading under DPHA

The reverse acquisition was completed on July 27, 2026. Peter Åsberg will participate in the bell ringing at Nasdaq Stockholm on August 21, 2026.

Media coverage

September 22 Finanznachrichten

Disruptive Pharma AB: Disruptive Pharma divests GTX platform and retains rights to future royalty and milestone revenues

Disruptive Pharma AB (publ) ("Disruptive Pharma" or the "Company") today announced that it has entered into an agreement to sell the GTX platform to a...

July 27 Finanznachrichten

Guard Therapeutics International AB: Guard Therapeutics Completes Reverse Takeover of Disruptive Pharma and Executes In-Kind Share Issue

July 2026 - Guard Therapeutics International AB (publ) (to be renamed Disruptive Pharma AB (publ)) ("Guard Therapeutics" or the "Company") today announces that the reverse...

July 16 Dagens industri

Guard Therapeutics gets to stay on NGM

The biotech company Guard Therapeutics has received conditional approval from Nasdaq Stockholm for continued listing of the company's shares on Nasdaq First North Growth Market, within the framework of the planned reverse acquisition of Disruptive Pharma.

June 11 The Wall Street Journal

Guard Therapeutics International AB

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least...

Never miss news about Disruptive Pharma

Track Disruptive Pharma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Disruptive Pharma competitors & trending companies

Browse news for competitors to Disruptive Pharma and other trending companies.